Jeevan Scientific Technology Share Price | Jeevan Scientific Technology Stock Screener
JSTL
Healthcare Technology
Share Price BSE
₹72.77
▲
0.84 (1.17%)
As of July 24, 2026, the Jeevan Scientific Technology share price (BSE: JSTL) is ₹72.77, up 1.17% from the previous close, with shares trading between ₹72.00 and ₹75.00, and a 52-week range of ₹33.98–₹89.43.
Analyse JSTL price trends and track historical price performance.
Use the Jeevan Scientific Technology stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Jeevan Scientific Technology Market Cap
₹143.64 Cr.
JSTL P/E Ratio (TTM)
141.29
Jeevan Scientific Technology P/B Ratio
2.01
EPS (TTM)
₹0.52
Dividend Yield
-
Debt to Equity
0.35
JSTL 52 Week High
₹89.43
Jeevan Scientific Technology 52 Week Low
₹33.98
Operating Margin
20.00%
Profit Margin
9.09%
JSTL Revenue (TTM)
₹22.00
EBITDA
₹5.00
Net Income
₹2.00
Total Assets
₹107.00
Total Equity
₹72.00
Jeevan Scientific Technology Share Price Chart
Screen Jeevan Scientific Technology share price with an interactive chart. Analyse JSTL price trends and volatility across different timeframes.
Jeevan Scientific Technology Company Profile - Fundamental Screener
Screen Jeevan Scientific Technology company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for JSTL shares.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
ISIN
INE237B01018
Jeevan Scientific Technology Balance Sheet Screener
Screen JSTL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 107 | 78 | 68 | 66 | 78 | 66 | 54 | 61 | 49 | 31 |
| Current Assets | 50 | 29 | 25 | 29 | 54 | 34 | 18 | 25 | 21 | 14 |
| Fixed Assets | 41 | 35 | 27 | 25 | 19 | 27 | 31 | 33 | 28 | 16 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 14 | 16 | 10 | 6 | 5 | 8 | 8 | 8 | 10 | 5 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 72 | 50 | 49 | 48 | 51 | 35 | 23 | 32 | 22 | 17 |
| Share Capital | 20 | 16 | 16 | 16 | 15 | 15 | 15 | 15 | 12 | 9 |
| Reserves & Surplus | 52 | 34 | 33 | 33 | 35 | 20 | 8 | 17 | 7 | 3 |
Jeevan Scientific Technology Income Statement Screener - Profit & Revenue Analysis
Screen Jeevan Scientific Technology income statement and profit fundamentals.
Analyze JSTL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Jeevan Scientific Technology share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22 | 10 | 9 | 13 | 19 | 11 | 13 | 12 | 13 | 8 | 11 | 8 | 10 | 17 | 11 |
| Expenses | 17 | 10 | 11 | 10 | 14 | 10 | 10 | 9 | 10 | 9 | 8 | 8 | 9 | 14 | 9 |
| EBITDA | 5 | 0 | -1 | 2 | 5 | 1 | 3 | 3 | 2 | -1 | 2 | 1 | 1 | 3 | 2 |
| Operating Profit % | 20.00% | -4.00% | -20.00% | 17.00% | 27.00% | 9.00% | 25.00% | 22.00% | 17.00% | -13.00% | 20.00% | 7.00% | 10.00% | -18.00% | 12.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 |
| Interest | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | -3 | -4 | 0 | 3 | -1 | 2 | 1 | 0 | -3 | 1 | -1 | -1 | 2 | 0 |
| Tax | 1 | -1 | -1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
| Net Profit | 2 | -1 | -3 | 0 | 2 | -1 | 1 | 0 | 0 | -2 | 1 | -1 | -1 | 1 | 0 |
| EPS | 0.92 | -0.81 | -2.03 | 0.01 | 1.52 | -0.47 | 0.66 | 0.16 | 0.03 | -1.51 | 0.33 | -0.39 | -0.31 | 0.52 | 0.25 |
Jeevan Scientific Technology Cash Flow Screener - Liquidity Fundamentals
Screen JSTL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 10 | 3 | -6 | 20 | 5 | 0 | 4 | 6 | -6 | 4 |
| Investing Activities | -16 | -12 | -7 | -1 | -1 | -2 | -8 | -14 | -9 | -4 |
| Financing Activities | 5 | 2 | -10 | 6 | 0 | 0 | 6 | 10 | 15 | 0 |
| Net Cash Flow | 0 | -6 | -23 | 24 | 4 | -2 | 2 | 1 | 0 | 0 |
Jeevan Scientific Technology Shareholding Pattern Screener
See Jeevan Scientific Technology shareholding pattern with promoter, FII, and DII holdings.
Check Jeevan Scientific Technology promoter holding and ownership changes for JSTL on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 30.25% | 38.05% | 38.05% | 38.05% | 38.05% | 38.70% | 38.70% | 38.70% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 55.79% | 42.99% | 42.75% | 42.76% | 46.56% | 45.50% | 45.34% | 45.75% |
| Other Holding | 13.96% | 18.96% | 19.21% | 19.19% | 15.39% | 15.80% | 15.96% | 15.55% |
| Shareholder Count | 5,053 | 5,497 | 5,460 | 5,444 | 5,159 | 5,749 | 5,655 | 5,607 |
Jeevan Scientific Technology Share Dividend Screener - Share Yield Analysis
Check Jeevan Scientific Technology dividend history with payout and yield data.
View Jeevan Scientific Technology dividend details including ex-dates and amounts for JSTL stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.20 | 2.38% |
| 2021-March | ₹0.50 | 0.38% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Jeevan Scientific Technology Stock Index Membership
See which indices include Jeevan Scientific Technology stock.
Check JSTL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Jeevan Scientific Technology Market Events Screener - Corporate Actions
Get Jeevan Scientific Technology corporate actions including splits, bonuses, and buybacks.
Check Jeevan Scientific Technology stock events that may affect JSTL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 1.88% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 0.00% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -4.42% |
| 2025-11-12 | 2025-11-12 | Extraordinary General Meeting | NA | 7.67% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | -8.88% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 7.49% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.73% |
| 2025-03-27 | 2025-03-27 | Extraordinary General Meeting | NA | -3.79% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 0.42% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | -0.11% |
| 2024-08-09 | 2024-08-09 | Annual General Meeting | NA | 11.55% |
| 2022-09-21 | 2022-09-23 | Dividend | ₹ 1.20 /share | -20.11% |
| 2021-09-07 | 2021-09-08 | Dividend | ₹ 0.50 /share | -1.73% |
Jeevan Scientific Technology Competitors Screener - Peer Comparison
Screen JSTL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 16,682 | 53.18 | 3,809 | 2.56% | 317 | 39.15 |
| Indegene | 12,234 | 30.59 | 3,511 | 19.14% | 349 | 48.53 |
| Suven Life Sciences | 8,978 | -34.64 | 7 | -59.60% | -276 | 60.98 |
| Vimta Labs | 2,678 | 35.09 | 322 | 0.22% | 41 | 42.78 |
| Take Solutions | 300 | 27.40 | 54 | 431.27% | 11 | 25.20 |
| Jeevan Scientific Technology | 144 | 141.29 | 62 | 29.56% | 2 | 39.99 |
| Bilcare | 143 | -8.46 | 734 | -9.05% | -21 | 53.19 |
| Adeshwar Meditex | 25 | 33.09 | 56 | -33.21% | 1 | 24.11 |
| Vanta Bioscience | 18 | 168.60 | 2 | -13.33% | 0 | 19.48 |
Jeevan Scientific Technology Company Announcements - News Screener
Screen JSTL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-22 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Notification Of Inspection For Addition Of Beds To The Existing Approved Bioavailability/Bioequivalence Center Of Jeevan Scientific Technology Limited. | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-05-29 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-29 | Statement Of Deviation Or Variation Of Funds | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-29 | Audited Financial Results For The Quarter And Year Ended 31.03.2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of Board Meeting Held On 29.05.2026 | - |
| 2026-05-21 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 29-05-2026 | - |
| 2026-04-30 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-04-30 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-30 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-04-30 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-25 | Closure of Trading Window | - |
| 2026-02-11 | Unaudited Financial Results For The Quarter Ended 31-12-2025. | - |
| 2026-02-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On 11-02-2026 | - |
| 2026-01-22 | Closure Of The United States Food And Drug Administration (US FDA) Remote Regulatory Assessment Of JSTL And Issuance Of The Remote Regulatory Assessment Report - Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |